| |  |
TABLE OF CONTENTS
|  |  |  | Volume 17, Issue 5 (July 2016) |  | In this issue Review Original Articles
Also new    AOP | |  |  |  | | Advertisement |  | BJC collections: Cancer Immunotherapy Immunotherapies have revolutionised therapy for some cancers. In parallel with therapeutic trials, many other mechanisms and pathways are being investigated in optimising these treatments. Access this collection from British Journal of Cancer - free online for six months Produced with support from: EMD Serono | | | |  |  | Review | Top |  | Gene–disease association with human IFNL locus polymorphisms extends beyond hepatitis C virus infectionsS Chinnaswamy Genes Immun 2016 17: 265-275; advance online publication, June 9, 2016; 10.1038/gene.2016.24 Abstract | Full Text |  | Original Articles | Top |  | Downregulation of ZBTB24 hampers the G0/1- to S-phase cell-cycle transition via upregulating the expression of IRF-4 in human B cellsJ Liang, R Yan, G Chen, J Feng, W-W Wu, W Ren, C Zhu, Y Zhao, X-M Gao and J Wang Genes Immun 2016 17: 276-282; advance online publication, April 21, 2016; 10.1038/gene.2016.18 Abstract | Full Text |  |  |  | Promoter H3K4 methylation dynamically reinforces activation-induced pathways in human CD4 T cellsS A LaMere, R C Thompson, H K Komori, A Mark and D R Salomon Genes Immun 2016 17: 283-297; advance online publication, May 12, 2016; 10.1038/gene.2016.19 Abstract | Full Text |  |  |  | Identification of genetic variants associated with susceptibility to West Nile virus neuroinvasive diseaseD Long, X Deng, P Singh, M Loeb, A S Lauring and M Seielstad Genes Immun 2016 17: 298-304; advance online publication, May 12, 2016; 10.1038/gene.2016.21 Abstract | Full Text |  |  |  | GWAS analysis implicates NF-κB-mediated induction of inflammatory T cells in multiple sclerosis OPENJ P Hussman, A H Beecham, M Schmidt, E R Martin, J L McCauley, J M Vance, J L Haines and M A Pericak-Vance Genes Immun 2016 17: 305-312; advance online publication, June 9, 2016; 10.1038/gene.2016.23 Abstract | Full Text |  |  |  | Phorbol ester-mediated re-expression of endogenous LAT adapter in J.CaM2 cells: a model for dissecting drivers and blockers of LAT transcription OPENK Marek-Bukowiec, E Aguado and A Miazek Genes Immun 2016 17: 313-320; advance online publication, June 9, 2016; 10.1038/gene.2016.25 Abstract | Full Text |  |  |  |  | | |  |  |  |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  | |  | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Genes and Immunity. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | | | |
No comments:
Post a Comment
Keep a civil tongue.